Today before the opening
bell, Actinium, a biopharmaceutical company developing innovative targeted
payload immunotherapeutics for the treatment of advanced cancers, reported that
it will be presenting at the 16th Annual BIO CEO & Investor Conference. The
conference is taking place Monday, February 10 to Tuesday, February 11, 2014 at
the Waldorf Astoria Hotel in New York City, New York. The company’s President
and CEO, Dr. Kaushik J. Dave will be presenting a company overview on Tuesday,
February 11, 2014 at 1:30 pm EST.
A telecast of the
presentation will be given. Investors and those seeking to watch the
presentation are advised to visit the following link for the presentation at
1:30 pm EST on February 11, 2014:
http://www.veracast.com/webcasts/bio/ceoinvestor2014/68234189.cfm.
Joining a few minutes ahead
of time is advisable, for best viewing results.
Actinium Pharmaceuticals is
a New York-based biopharmaceutical company developing innovative targeted
payload immunotherapeutics for the treatment of advanced cancers. Actinium’s
targeted radiotherapy is based on its proprietary delivery platform for the
therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and
certain beta emitting radiopharmaceuticals in conjunction with monoclonal
antibodies. The Company’s lead radiopharmaceutical Iomab(TM)-B will be used in
preparing patients for hematopoietic stem cell transplant, commonly referred to
as bone marrow transplant.
For more information, visit:
www.actiniumpharmaceuticals.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
